Angiotensin II promotes aortic valve thickening independent of elevated blood pressure in apolipoprotein-E deficient mice

Atherosclerosis

Volumn 226, Issue 1, 2013, Pages 82-87

  Fujisaka, Tomohiro ^a   Hoshiga, Masaaki ^a   Hotchi, Junko ^a   Takeda, Yoshihiro ^a   Jin, Denan ^a   Takai, Shinji ^a   Hanafusa, Toshiaki ^a   Ishizaka, Nobukazu ^a  

^a OSAKA MEDICAL COLLEGE   (Japan)

Author keywords

Angiotensin; Aortic valve; Atherosclerosis; Hypertension

Indexed keywords

ANGIOTENSIN II; APOLIPOPROTEIN E; HYDRALAZINE; OLMESARTAN;

ABDOMINAL AORTA; ABDOMINAL AORTA ANEURYSM; ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA VALVE; AORTA VALVE THICKNESS; ARTICLE; BLOOD PRESSURE; BRACHIOCEPHALIC TRUNK; CONTROLLED STUDY; DILATATION; ECHOCARDIOGRAPHY; ENDOTHELIUM CELL; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; MALE; MOUSE; MYOFIBROBLAST; NONHUMAN; PRIORITY JOURNAL; THICKNESS;

ANGIOTENSIN II; ANIMALS; AORTIC VALVE; AORTIC VALVE STENOSIS; APOLIPOPROTEINS E; ATHEROSCLEROSIS; HYPERTENSION; MALE; MICE; MICE, INBRED C57BL;

EID: 84871385153     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2012.10.055     Document Type: Article

References (29)

1. Otto C.M., Lind B.K., Kitzman D.W., Gersh B.J., Siscovick D.S. Association of aortic-valve sclerosis with cardiovascular mortality and morbidity in the elderly. N Engl J Med 1999, 341:142-147.
2. Iung B., Baron G., Butchart E.G., et al. A prospective survey of patients with valvular heart disease in Europe: the Euro heart survey on valvular heart disease. Eur Heart J 2003, 24:1231-1243.
3. Newby D.E., Cowell S.J., Boon N.A. Emerging medical treatments for aortic stenosis: statins, angiotensin converting enzyme inhibitors, or both?. Heart 2006, 92:729-734.
4. Otto C.M., Kuusisto J., Reichenbach D.D., Gown A.M., O'Brien K.D. Characterization of the early lesion of 'degenerative' valvular aortic stenosis. Histological and immunohistochemical studies. Circulation 1994, 90:844-853.
5. Tanaka K., Sata M., Fukuda D., et al. Age-associated aortic stenosis in apolipoprotein E-deficient mice. J Am Coll Cardiol 2005, 46:134-141.
6. Rajamannan N.M., Subramaniam M., Springett M., et al. Atorvastatin inhibits hypercholesterolemia-induced cellular proliferation and bone matrix production in the rabbit aortic valve. Circulation 2002, 105:2660-2665.
7. Weiss R.M., Ohashi M., Miller J.D., Young S.G., Heistad D.D. Calcific aortic valve stenosis in old hypercholesterolemic mice. Circulation 2006, 114:2065-2069.
8. Aikawa E., Nahrendorf M., Sosnovik D., et al. Multimodality molecular imaging identifies proteolytic and osteogenic activities in early aortic valve disease. Circulation 2007, 115:377-386.
9. Chan K.L., Teo K., Dumesnil J.G., Ni A., Tam J. Effect of Lipid lowering with rosuvastatin on progression of aortic stenosis: results of the aortic stenosis progression observation: measuring effects of rosuvastatin (ASTRONOMER) trial. Circulation 2010, 121:306-314.
10. Nishimoto M., Takai S., Kim S., et al. Significance of chymase-dependent angiotensin II-forming pathway in the development of vascular proliferation. Circulation 2001, 104:1274-1279.
11. Helske S., Lindstedt K.A., Laine M., et al. Induction of local angiotensin II-producing systems in stenotic aortic valves. J Am Coll Cardiol 2004, 44:1859-1866.
12. Helske S., Syvaranta S., Kupari M., et al. Possible role for mast cell-derived cathepsin G in the adverse remodelling of stenotic aortic valves. Eur Heart J 2006, 27:1495-1504.
13. Ngo D.T., Stafford I., Sverdlov A.L., et al. Ramipril retards development of aortic valve stenosis in a rabbit model: mechanistic considerations. Br J Pharmacol 2011, 162:722-732.
14. Arishiro K., Hoshiga M., Negoro N., et al. Angiotensin receptor-1 blocker inhibits atherosclerotic changes and endothelial disruption of the aortic valve in hypercholesterolemic rabbits. J Am Coll Cardiol 2007, 49:1482-1489.
15. Simolin M.A., Pedersen T.X., Bro S., et al. ACE inhibition attenuates uremia-induced aortic valve thickening in a novel mouse model. BMC Cardiovasc Disord 2009, 9:10.
16. Darby I., Skalli O., Gabbiani G. Alpha-smooth muscle actin is transiently expressed by myofibroblasts during experimental wound healing. Lab Invest 1990, 63:21-29.
17. Roosens B., Bala G., Droogmans S., Van Camp G., Breyne J., Cosyns B. Animal models of organic heart valve disease. Int J Cardiol 2012.
18. Drolet M.C., Arsenault M., Couet J. Experimental aortic valve stenosis in rabbits. J Am Coll Cardiol 2003, 41:1211-1217.
19. Matsumoto Y., Adams V., Jacob S., Mangner N., Schuler G., Linke A. Regular exercise training prevents aortic valve disease in low-density lipoprotein-receptor-deficient mice. Circulation 2010, 121:759-767.
20. Hamilton A.M., Boughner D.R., Drangova M., Rogers K.A. Statin treatment of hypercholesterolemic-induced aortic valve sclerosis. Cardiovasc Pathol 2011, 20:84-92.
21. Cuniberti L.A., Stutzbach P.G., Guevara E., Yannarelli G.G., Laguens R.P., Favaloro R.R. Development of mild aortic valve stenosis in a rabbit model of hypertension. J Am Coll Cardiol 2006, 47:2303-2309.
22. Poggianti E., Venneri L., Chubuchny V., Jambrik Z., Baroncini L.A., Picano E. Aortic valve sclerosis is associated with systemic endothelial dysfunction. J Am Coll Cardiol 2003, 41:136-141.
23. O'Brien K.D., Probstfield J.L., Caulfield M.T., et al. Angiotensin-converting enzyme inhibitors and change in aortic valve calcium. Arch Intern Med 2005, 165:858-862.
24. Nadir M.A., Wei L., Elder D.H., et al. Impact of renin-angiotensin system blockade therapy on outcome in aortic stenosis. J Am Coll Cardiol 2011, 58:570-576.
25. Uchida H.A., Kristo F., Rateri D.L., et al. Total lymphocyte deficiency attenuates AngII-induced atherosclerosis in males but not abdominal aortic aneurysms in apoE deficient mice. Atherosclerosis 2010, 211:399-403.
26. Wakui H., Tamura K., Matsuda M., et al. Intrarenal suppression of angiotensin II type 1 receptor binding molecule in angiotensin II-infused mice. Am J Physiol Ren Physiol 2010, 299:F991-F1003.
27. Ishizaka N., Alexander R.W., Laursen J.B., et al. G protein-coupled receptor kinase 5 in cultured vascular smooth muscle cells and rat aorta. Regulation by angiotensin II and hypertension. J Biol Chem 1997, 272:32482-32488.
28. Daugherty A., Cassis L.A. Mouse models of abdominal aortic aneurysms. Arterioscler Thromb Vasc Biol 2004, 24:429-434.
29. Li L., Zhou N., Gong H., et al. Comparison of angiotensin II type 1-receptor blockers to regress pressure overload-induced cardiac hypertrophy in mice. Hypertens Res 2010, 33:1289-1297.